Background.
With the rising use of midline catheters (MC), validation of their safety is essential. The objective of our study was to evaluate the incidence of bloodstream infections (BSI) and other complications related to the use of MC and central venous catheter (CVC).
Methods. A retrospective cohort study was performed from May-December 2016 at Detroit Medical Center, Detroit, MI. Adult patients were eligible for inclusion if they had either MC or CVC during hospitalization. Outcomes assessed were line-related BSI per the National Healthcare Service Network (NHSN) criteria, mechanical complications (nonfunctional line due to disruption in patency or dislodging), hospital length of stay, mortality and readmission within 90 days of discharge. Statistical analysis was performed using SAS software.
Results. A total of 312 patients with MC and 215 patients with CVC were analyzed. The mean age of cohort was 57 ± 17.4 years and 52% were females. Higher catheter-related BSIs (CRBSI) were seen in patients with CVC (7/215) compared with MC (1/312); (3.3 vs. 0.3%; P = 0.009). Among the CRBSI, alternative source of infection was identified in both MC (1/1) and CVC group (2/7). Two of the 7 CVC-related BSI were reported to NHSN. More mechanical complications were seen in MC (3.5%) compared with CVC group (0.4%) (P = 0.03). Patients with CVC had higher crude mortality (14% vs 6%, P = 0.002), readmission rate (51% vs 38%, P = 0.004) and line-related readmissions (5.7% vs 0.8%, P = 0.05) compared with MC group. Multivariate analysis showed female gender (OR 0.55, 95% CI 0.38-0.81), burns (OR 0.21, 95% CI 0.06-0.74), myocardial infarction (OR 0.17, 95% CI 0.08-0.36) and stay in the intensive care unit (OR 0.60, 95% CI 0.41-0.88) had higher likelihood to receive MC while CVC was more likely to be inserted in patients with chronic kidney disease (OR 2.86, 95% CI 1.84-4.44).
Conclusion. Patients with chronic kidney disease are more likely to get CVC and hence particular attention should be paid to prevent BSI through appropriate catheter care. MC are more common in patients with burns, myocardial infarction and in the intensive care unit. Larger studies are needed to understand if MC or CVC are independent predictors for BSI.
Disclosures. All authors: No reported disclosures. Background. Extracorporeal membrane oxygenation (ECMO) has been used in various clinical settings, such as acute respiratory distress syndrome, cardiogenic shock and refractory septic shock. One of the associated risks is acquisition of infections during bypass because of the multiple cannulation sites. The purpose of this study was to evaluate the predictors of healthcare associated infections (HAI) and mortality in adult patients on ECMO.
Predictors of Infections and Mortality in Adult Patients
Methods. This was a retrospective descriptive study at a 1550 bed Universityaffiliated tertiary medical center in Miami, Florida. We looked at patients over 18 years old on ECMO for > 48 hours between January 1-August 31, 2016. The presence of an infection before ECMO placement or acquired during ECMO support were noted. Only culture-proven infections were included. The primary outcome was to identify risk factors associated with HAI or mortality.
Results. 40 patients undergoing ECMO during the study period were identified. 25 patients met the inclusion criteria and were included in the analysis. During a total of 364 ECMO days, 12 patients out of 25 had microbiologically proven infection (48 %). There were 7 ventilator associated pneumonias (41%), 5 bacteremias (29%), 2 pleural empyemas (12%), 2 Clostridium difficile colitis (12%) and 1 mediastinitis (6%). Candida species were the predominant blood isolates (60%). The rate of infection per 1,000 ECMO days was 46.7.
The overall in-hospital mortality was 64%. There was no impact of infection on mortality, length of ICU,or hospital stay. ECMO use for < 7 days was associated with overall less episodes of infection vs ECMO use for > 7 days. (P-value 0.0136, OR 0.089, CI: 0.01-0.6). Charlson-comorbidity score of 5 or more was associated with higher episodes of bacteremia (P = 0.0023, OR = 16, CI = 1.38-185.41).
Conclusion. Infections did not have an impact on mortality. Patients on ECMO for less than 8 days had less episodes of infections. Patients with Charlson-comorbidity index of 5 or more were associated with higher episodes of bacteremia. Further prospective cohort studies are necessary to address causality and to determine infection and mortality predictors that can be modified for patients undergoing ECMO.
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